Followers | 7 |
Posts | 591 |
Boards Moderated | 0 |
Alias Born | 04/18/2005 |
Tuesday, February 25, 2014 5:19:42 PM
I agree. Logic dictates everything your gut is telling you. Any number of BP’s should have made an offer to partner or merge long… long ago. Since this isn’t the case, either:
1) King’s demands/expectations are beyond unreasonable in these half decade long “talks” or
2) Based on BP’s due diligence, they simply aren’t convinced that “value” is there yet to make a move.
Expecting that Peregrine is going to enroll 600 patients in the phase 3 study in 24 months is wishful thinking with the company’s lack of promotion and “believability”… We needed a CEO with a proven track record of “delivering” to have been promoting Bavi A/C for a long time….The fact is, King’s n’th dog and pony shows are proven to be of little value. The information is nice, no doubt, but the well documented track record of seldom meeting expectations and self-imposed deadlines is proving to be a hindrance in how the overall message is received.
I remember the regulars on this board jumping for joy about the “potential” of the imaging trial….have we even enrolled 5 people in 2 years yet? Again, lack of enthusiasm being fostered by the person delivering the message is materially impacting the programs in a negative way not to mention the share price at which the dilution is occurring that ultimately crushes the upside potential of longtime shareholders. Like it or not, these downstream impacts are the direct result of talking and not doing over a long period of time. It is almost March, and the liver trail can’t even complete enrolling when it has been described that almost nothing can be combined with the SOC effectively. Can anyone offer a valid reason why enrollment timeframe would be so disappointing? The pages on the calendar keep blowing by while the dilution machine keeps running and the progress keeps crawling. I believe that this “go it alone” strategy has been a disaster as it relates to a variety of other trials that should be funded but haven’t been over the last half decade. Let’s hop in a time machine and go back to the time when the Georgia and India phase 2 trials concluded. Had we partnered then….even resulting in a vanilla deal, the program would have been way further along by now and the long-term shareholders would have been way better off and could imagine a market cap in the billions by now with a late stage breast cancer trial hitting on all cylinders.
Someone posted earlier that Bavi will succeed in spite of the CEO…I concur. Unfortunately, at this rate we may be very well be facing yet another negative variable whereby Bavi succeeds and while the shareholders….were “right”, may just miss out on financially benefitting in the event a currency crisis takes place before this endeavor is “monetized”.
Let’s hope that something positive transpires real soon. I have to believe this new hire assisting King knows how to play this game, my only concern is King going overboard playing hard-ass with what otherwise would be deemed to be fair offers from potential suitors.
All IMHO
Recent CDMO News
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM